ArticleMolecular medicine reports2015

Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer.

Yan Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.